Parexel
Australia's Clinical Trials Infrastructure and Innovations
Pages
10
Time to read
14 mins
Publication
Language
English
Pages
10
Time to read
14 mins
Publication
Language
English
This technical report examines the landscape for clinical trials in Australia, focusing on infrastructure, government funding support, patient recruitment, and innovation adoption. It outlines the advantages of conducting clinical trials in Australia, including a stable environment, experienced workforce, and high-quality data production. The report details the distribution of clinical trial sites across various states and highlights the significance of Early Phase trials, particularly in oncology. It presents information on Australia's R&D tax incentives aimed at boosting competitiveness and productivity in the clinical research sector. Additionally, the report discusses the Medical Research Future Fund and its role in supporting health and medical research. The therapeutic areas of study are primarily oncology and autoimmune/inflammatory fields, with a significant focus on improving patient-centricity in trial designs. The report emphasizes the importance of understanding patient needs and employing digital technologies to enhance recruitment and participation in clinical trials.